Desensitization of pigment granule aggregation in Xenopus leavis melanophores:: melatonin degradation rather than receptor down-regulation is responsible

被引:3
作者
Teh, MT [1 ]
Sugden, D [1 ]
机构
[1] Kings Coll London, Sch Biomed Sci, Endocrinol & Reprod Res Grp, London SE1 1UL, England
关键词
deacetylation; desensitization; melatonin; melatonin receptor; pigment aggregation; Xenopus melanophores;
D O I
10.1046/j.1471-4159.2002.00885.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Xenopus laevis melanophores express a high density (B-max 1224 fmol/mg protein) of high-affinity (K-d 37 pM) cell membrane melatonin receptors. Treatment of melanophores with melatonin resulted in a loss of membrane melatonin receptors reaching a maximum (similar to60%) by 6 h. In addition to receptor loss, a decline in the potency of melatonin to produce pigment aggregation was observed on prolonged treatment. However, the loss of potency (3.8-fold in 24 h and 162-fold in 96 h) was much slower than loss of receptors, and was completely prevented by inclusion of eserine (100 muM), an inhibitor of melatonin deacetylation in the culture medium. Incubation of melanophores with [H-3]-melatonin showed that eserine prevented metabolism of melatonin to 5-methoxytryptamine. These results indicate that although receptor density does decline on prolonged treatment, this is not responsible for the diminishing melatonin potency, which is entirely due to degradation of melatonin by deacetylation and subsequent deamination in melanophores.
引用
收藏
页码:719 / 727
页数:9
相关论文
共 40 条
[31]   MELATONIN INHIBITS PROLIFERATION AND MELANOGENESIS IN RODENT MELANOMA-CELLS [J].
SLOMINSKI, A ;
PRUSKI, D .
EXPERIMENTAL CELL RESEARCH, 1993, 206 (02) :189-194
[32]   MELATONIN - BINDING-SITE CHARACTERISTICS AND BIOCHEMICAL AND CELLULAR-RESPONSES [J].
SUGDEN, D .
NEUROCHEMISTRY INTERNATIONAL, 1994, 24 (02) :147-157
[33]   Melatonin receptor pharmacology: toward subtype specificity [J].
Sugden, D ;
Pickering, H ;
Teh, MT ;
Garratt, PJ .
BIOLOGY OF THE CELL, 1997, 89 (08) :531-537
[34]   Design of subtype selective melatonin receptor agonists and antagonists [J].
Sugden, D ;
Yeh, LK ;
Teh, MT .
REPRODUCTION NUTRITION DEVELOPMENT, 1999, 39 (03) :335-344
[35]   Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists:: Lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores [J].
Teh, MT ;
Sugden, D .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (05) :522-528
[36]   The putative melatonin receptor antagonist GR128107 is a partial agonist on Xenopus laevis melanophores [J].
Teh, MT ;
Sugden, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (05) :1237-1245
[37]   PHYSIOLOGICAL REGULATION OF MELATONIN RECEPTORS IN RAT SUPRACHIASMATIC NUCLEI - DIURNAL RHYTHMICITY AND EFFECTS OF STRESS [J].
TENN, C ;
NILES, LP .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1993, 98 (01) :43-48
[38]   Cellular mechanisms of melatonin action [J].
Vanecek, J .
PHYSIOLOGICAL REVIEWS, 1998, 78 (03) :687-721
[39]   Melatonin inhibits calcitonin gene-related peptide-induced vasodilation and increase in cAMP in rat middle cerebral arteries [J].
Viswanathan, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 415 (2-3) :247-250
[40]  
WittEnderby PA, 1996, MOL PHARMACOL, V50, P166